pharmaphorum

NOVEMBER 16, 2022

There’s plenty in the pipeline to entice a potential buyer, however, including several mid-stage clinical candidates, such as EPO inhibitor LKA651 for diabetic retinopathy, Factor B inhibitor iptacopan for AMD, and gene therapy PPY988 for geographic atrophy.

Sales 117

Sales Prescription Medicine Media 117

Pharmaceutical Technology

AUGUST 1, 2022

The company will jointly design and analyse messenger ribonucleic acid (mRNA) Covid-19 vaccines in partnership with the NIH unit National Institute of Allergy and Infectious Diseases’ Vaccine Research Center (VRC). The human health product candidates of GreenLight are currently in the pre-clinical stage.

Marketing 98

Marketing Pharmaceutical Manufacturing 98

Pharmaceutical Technology

SEPTEMBER 16, 2022

The latest conditional recommendation is based on the final data from the SOLIDARITY clinical trial, which was sponsored by the WHO. These results are in line with those obtained from the placebo-controlled, double-blind ACTT-1 trial of the National Institute of Allergy and Infectious Diseases.

Food and Drug Administration 110

Food and Drug Administration Food Patients Medical 110

pharmaphorum

NOVEMBER 11, 2022

Leading with practical insights from the best in the industry, the 4th Annual Inflammasome Therapeutics Summit is returning in person on November 29 – December 1 to Boston to equip you with the knowledge and connections to propel the next frontier of inflammasome therapeutics from pipeline to clinical and commercial reality.

Medicine 52

Medicine Medical Leads Pharma 52

Pharmaceutical Technology

OCTOBER 6, 2022

from the US National Institutes of Health (NIH) unit National Institute of Allergy and Infectious Diseases (NIAID) to develop a prophylactic intranasal vaccine against Neisseria gonorrhoeae (NG). Intravacc has received a contract worth $14.6m Leveraging its outer membrane vesicles (OMV) platform technology, Intravacc will develop the vaccine.

Manufacturing 59

Manufacturing Safety Pharmaceutical 59

European Pharmaceutical Review

JULY 13, 2022

The US National Institute of Allergy and Infectious Diseases (NIAID) has launched a Phase I clinical trial to evaluate a messenger RNA (mRNA) vaccine developed to prevent infection with Nipah virus. NIAID is sponsoring the Phase 1 study ( NCT05398796 ), which is being conducted at the NIH Clinical Center in Bethesda, Maryland. .

Safety 82

Safety Manufacturing Leads Pharmaceutical 82

pharmaphorum

NOVEMBER 9, 2022

The FDA’s Pulmonary-Allergy Drugs Advisory Committee (PADAC) voted by 16 to one that PT027 should be approved for use in adults. And for younger children the vote was 16 to one against, mainly on the grounds that there were too few patients in these age brackets in AZ’s clinical trials to give a meaningful view of efficacy.

FDA 59

FDA Patients Marketing Sales 59

European Pharmaceutical Review

AUGUST 9, 2023

In REMIX-2, the clinical trial enrolled 455 participants with CSU. The REMIX data for Novartis’ novel BTK inhibitor will be presented at an upcoming medical meeting. The pharmaceutical company announced that it plans to submit to global health authorities in 2024. There were 470 participants in the REMIX-1 study.

Safety 72

Safety Medical Patients Pharmaceutical 72

pharmaphorum

JANUARY 12, 2023

Avillion – clinical co-development partner with AZ – conducted the global phase 3 trial of over 4,000 patients across four studies (including the MANDALA and DENALI trials). The new approval continues the company’s unmarred success rate in clinical co-development partnerships across multiple therapeutic areas.

FDA 52

FDA Food and Drug Administration Medical Patients 52

European Pharmaceutical Review

OCTOBER 21, 2022

Clinical trial results presented at the US IDWeek conference, revealed a three-dose series of the HEPLISAV-B vaccine prevents hepatitis B virus (HBV) in HIV patients not previously vaccinated against or infected with the virus. The clinical trial is estimated to be completed in March 2023.

Patients 76

Patients Food and Drug Administration Side effects Food 76

European Pharmaceutical Review

JULY 13, 2022

Afrigen Biologics and the US National Institute of Allergy and Infectious Diseases (NIAID) have agreed to share technical expertise related to the development of next-generation messenger RNA (mRNA) vaccines and therapeutics. . Site visits are planned, with Afrigen expected to visit the VRC in Maryland, US, later this year. .

Manufacturing 74

Manufacturing Medicine Management Pharmaceutical 74

Pharmaceutical Technology

JUNE 10, 2023

TAS-117 is under clinical development by Taiho Pharmaceutical and currently in Phase II for Chondrosarcoma. Attributes of the drug, company and its clinical trials play a fundamental role in drug-specific PTSR and likelihood of approval. It was under development for the treatment of gastric cancer and multiple myeloma.

Pharmaceutical 40

Pharmaceutical Pharmaceutical products Medicine Competition 40

Pharmaceutical Technology

JUNE 10, 2023

TAS-117 is under clinical development by Taiho Pharmaceutical and currently in Phase II for Chondrosarcoma. Attributes of the drug, company and its clinical trials play a fundamental role in drug-specific PTSR and likelihood of approval. It was under development for the treatment of gastric cancer and multiple myeloma.

Pharmaceutical 40

Pharmaceutical Pharmaceutical products Medicine Competition 40

pharmaphorum

AUGUST 12, 2022

Patient recruitment specialist Clariness will deploy an app aimed at helping asthma patients monitor environment triggers and report symptoms in the clinical trials its support, thanks to a partnership with digital health firm DailyBreath. The post Clariness, DailyBreath partner to drive recruitment in asthma trials appeared first on.

Recruitment 52

Recruitment Patients Doctors Medical 52

pharmaphorum

OCTOBER 11, 2022

It is subject to a two-year clinical stopping rule, as for now it remains uncertain the benefits of the regimen extend beyond that timepoint and whether continuing to give it will remain cost-effective, according to the SMC’s assessment document.

Medicine 52

Medicine Patients Leads Marketing 52

Pharmaceutical Technology

JUNE 8, 2023

Publication of these results in Nature Communications supports the scientific rigor of our work and potential clinical utility of our next-generation vaccine platform for the prevention of infectious diseases, including coronaviruses, such as Covid-19,” said Andrew Allen, Chief Executive Officer of Gritstone.

Safety 52

Safety Management 52

Pharmaceutical Technology

APRIL 26, 2023

Dr. Amy Chan, senior clinical research fellow at the School of Pharmacy, University of Auckland, says digital inhalers have existed for almost 30 years. In a 2020 study, Chan found devices that can easily calculate adherence to activation and inhalation could have the greatest utility in clinical practice.

Electronics 115

Electronics Medical Patients Healthcare 115

Pharmaceutical Technology

DECEMBER 7, 2022

Sanofi and Regeneron’s Dupixent had previously been linked to conjunctivitis, an eye condition usually caused by allergies or an infection. This symptom, captured previously in clinical trials for the drug, was typically mild, but it is known to worsen without proper management and care.

Side effects 64

Side effects Food and Drug Administration Safety Physicians 64

Referral MD

JULY 5, 2022

After implementing the 2009 Health Information Technology for Economic and Clinical Health (HITECH) Act, US clinics were provided sufficient funds to adapt to newer electronic practices in data recording. “Beyond standard clinical data collected in a provider’s office, including a broader view of a patient’s care.”

Electronics 52

Electronics Healthcare Healthcare Medical 52

Celeritas

NOVEMBER 30, 2022

However, two of the greatest concerns in the veterinary field are the understaffing of veterinarian clinics and the lack of urgent care available to pets as a result. And animal owners often have their hands full while at the clinics, keeping an eye on their little dependent. That is where the Animal Health Portal comes into play.

Prescription 98

Prescription Medical Management Consulting 98

Pharmaceutical Technology

JANUARY 8, 2023

There are at least six different biologics being studied in Phase III trials in COPD clinical programmes around the world. With three votes for and 16 against, the US Pulmonary Allergy Drugs Advisory Committee refused its use as an add-on treatment to inhaled corticosteroid-based maintenance.

Patients 119

Patients FDA Pharmaceutical Pharma 119

pharmaphorum

JULY 28, 2022

Development in peanut allergy has also been discontinued, said Sanofi in its second-quarter update. The performance of Dupixent and solid performances from its rare disease and consumer health divisions have allowed Sanofi to raise its forecasts (PDF) for earnings growth from low double-digits to 15%.

Sales 59

Sales FDA Medicine Leads 59

PM360

JUNE 29, 2022

The retailer has been gradually building out its network of in-store clinics—a bricks-and-mortar presence that will be complemented by its virtual care offering. Their goal is to accelerate the opening of at least 600 Village Medical clinics at Walgreens primary care practices in more than 30 U.S.

Retail 97

Retail Healthcare Healthcare Marketing 97

pharmaphorum

JULY 12, 2022

Researchers in the US have started a clinical trial of a vaccine against Nipah virus, a serious infection caught from animals that has a fatality rate of between 40% and 70%, developed by mRNA specialist Moderna. “The need for a preventive Nipah virus vaccine is significant,” he added.

Safety 52

Safety Leads 52

pharmaphorum

NOVEMBER 3, 2022

.” The number of NGF inhibitors in development has been steadily winnowed down in recent years, mainly due to toxicity issues, and until last year fasinumab was one of two remaining candidates in clinical testing. The post And then there were none: Regeneron cans last late-stage NGF drug appeared first on.

Safety 52

Safety Medicine FDA Pharma 52

pharmaphorum

NOVEMBER 30, 2022

Working in the allergy and autoimmune space, COUR looks at nanoparticles and allergens – such as peanut and coeliac (which he had experience with whilst at Takeda) – and infuses these into patients as a treatment so that the body accepts it because of the precise combination technology, patients forming a tolerance to the antigen.

Pharma 88

Pharma Consulting Marketing Sales 88

World of DTC Marketing

NOVEMBER 19, 2021

This includes almost the entire cost of clinical development. In 2015, the National Institute of Allergy and Infectious Diseases, an institute within the NIH, signed a cooperative R&D agreement with Moderna on basic research, including new vaccines. SUMMARY: The U.S. government made available to them to make this COVID-19 vaccine.

Government 44

Government Pharma Marketing Sales 44

Pharma Marketing Network

APRIL 27, 2021

Rod joined Pfizer in Sandwich, UK as a Research Scientist and conducted medicinal chemistry research in the cardiovascular, GI, Sexual Health, Urology and Allergy & Respiratory diseases. Rod MacKenzie, PhD, is Chief Development Officer and Executive Vice President for Pfizer. Rod is the co-inventor of darifenacin (Enablex ).

Medicine 52

Medicine Networking Safety Marketing 52

pharmaphorum

JULY 7, 2022

Once the pandemic hit, Moderna teamed up with the US National Institute of Allergy and Infectious Diseases (NIAID) to co-develop the former’s vaccine. The institute also led and funded early-stage clinical research into the vaccine candidate.

Government 82

Government 82

Nixon Gwilt Law

NOVEMBER 3, 2022

Your affiliated clinicians want information from their patients that they can’t access via video consult—blood glucose tests, allergy tests, urine screening, throat cultures. Some companies start as laboratories and expand to provide clinical care, but most commonly the reverse is true. And now you’re hitting roadblocks.

Physicians 59

Physicians Healthcare Provider Healthcare Healthcare 59

Pharmaceutical Technology

FEBRUARY 3, 2023

The Janssen vaccines studied in the Imbokodo and Mosaico studies were based on the mosaic concept, where they were intentionally designed to include a broader immunogen that could be used everywhere, says Dr. Mary Marovich, director of the Vaccine Research Program at National Institute of Allergy and Infectious Diseases (NIAID).

Medicine 117

Medicine Prospecting Safety Manufacturing 117

Cesare Ferrari

SEPTEMBER 25, 2022

For example, milder cases with lifestyle changes , such as losing weight, quitting smoking, and treatment for allergies. The technical data, clinical evidence, and promotional messages will be similar. Similarly, for the treatment of obstructive sleep apnea , there are several options available.

Competition 52

Competition Marketing Medical Sales 52

PM360

AUGUST 29, 2022

Relaxium – Part-time Musician (Clinically Proven). According to a recent report, 50 million Americans are suffering from an allergy season that’s longer, more severe, and affecting more people than ever before. Relaxium – Part-time Musician. Impressions. 148 million. Searches Generated from Creative. Brand / Creative.

Pharma 98

Pharma Prescription Marketing Pharmaceutical Sales 98

Medico Reach

FEBRUARY 17, 2023

While the second helps you connect with licensed professional counselors, family and marriage therapists, clinical social workers, instantly. Customers can easily make an appointment when necessary to obtain treatment virtually quickly for common problems and conditions like Flu, Minor rashes, pink eye, allergies, etc.

Doctors 40

Doctors Healthcare Healthcare Physicians 40

PM360

AUGUST 9, 2022

The system generates targeted analytics that are updated daily and integrated into the various clinical workflows to prioritize high-risk patients and guide personalized outreach. and for research use cases, such as clinical trials, decentralized clinical trials (DCT), real-world evidence (RWE) studies, etc. Jennifer DiGennaro.

Prescription 105

Prescription Medical Side effects Patients 105

European Pharmaceutical Review

DECEMBER 6, 2023

Dupilumab is used widely as an allergy and asthma treatment, stated the authors of the corresponding research paper, which has been published in Nature. The investigators highlighted in the paper that “one out of six patients, drove a near-complete clinical response two months after treatment.” In the paper, LaMarche et al.

Patients 100

Patients Medical Medicine Pharmaceutical 100

Healthcare Success

MAY 9, 2022

Medical Clinics. Just like hospitals, medical clinics and private practice doctors can also benefit from using QR codes. . expiration dates, composition, drug interactions, dosage, allergy information, and more). . Patient information. They can use QR codes to display important information on medicines (e.g.,

Leads 112

Leads Patients Healthcare Provider Healthcare 112